Drawing for KOURION

USPTO serial 76172250

KOURION

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
HICKEY,TONI
Law office
TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with KOURION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Patricia A Walker

PATRICIA A WALKER WALKER & JOCKE231 S BROADWAYMEDINA, OH 44256-2601UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001celltherapeutic and stemcell transplant diagnostic preparations for scientific and research; regenerative cell, tissue, and organic preparations for scientific and research use; and clinical testing preparations, namely, preparations from stemcells or differentiated and modified stemcells for scientific and research useACTIVE—
005pharmaceutical cell preparations as human medicine, namely, for use in the treatment of diseases such as but not limited to degenerative diseases of the liver (eg. cirrhosis), heart (eg. infarct, congestive heart failure), brain and spine (eg. Parkinson's disease, stroke, paralysis, spinal injuries), bone (eg. tumor resections, degenerative bone disease), cartilage (eg. meniscal tears, vertebral discs), pancreas (type I diabetes), vascular disease, degenerative muscle diseases and for hematopoietic reconstitution after cancer treatment; celltherapeutic and stemcell transplant diagnostic preparations for clinical and medical laboratory use; celltherapeutic and stemcell transplant diagnostic reagents; Adjuvant substance for the stemcell therapy; regenerative cell, tissue, and organic preparations for clinical or medical laboratory use; medical reagents, namely, regenerative cell, tissue and organic reagents; stemcells or differentiated and modified stemcell preparations for clinical and medical laboratory use; and medical reagents, namely, stemcells and differentiated and modified stemcell reagentsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jul 9, 2007MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 7, 2007ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Dec 7, 2006CNSIINQUIRY AS TO SUSPENSION MAILED—
Dec 6, 2006CNSISUSPENSION INQUIRY WRITTEN—
Jun 9, 2006DPCCDIVISIONAL PROCESSING COMPLETE—
Jun 5, 2006CNSLLETTER OF SUSPENSION MAILED—
Jun 3, 2006CNSLSUSPENSION LETTER WRITTEN—
May 5, 2006TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 11, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 11, 2006TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 8, 2006DRRRDIVISIONAL REQUEST RECEIVED—
Feb 8, 2006MAILPAPER RECEIVED—
Jan 9, 2006CNSIINQUIRY AS TO SUSPENSION MAILED—
Jan 7, 2006CNSISUSPENSION INQUIRY WRITTEN—
Jun 24, 2005CNSLLETTER OF SUSPENSION MAILED—
Jun 23, 2005CNSLSUSPENSION LETTER WRITTEN—
Jun 23, 2005TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 6, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 6, 2005TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 13, 2004CNSIINQUIRY AS TO SUSPENSION MAILED—
Dec 11, 2004CNSISUSPENSION INQUIRY WRITTEN—
Dec 11, 2004RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
May 24, 2004CNSLLETTER OF SUSPENSION MAILED—
May 8, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 8, 2004TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 12, 2003CNSIINQUIRY AS TO SUSPENSION MAILED—
Oct 21, 2003CFITCASE FILE IN TICRS—
Apr 10, 2003CNSLLETTER OF SUSPENSION MAILED—
Feb 7, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 7, 2003MAILPAPER RECEIVED—
Oct 28, 2002CNSIINQUIRY AS TO SUSPENSION MAILED—
Oct 15, 2002DOCKASSIGNED TO EXAMINER—
Apr 23, 2002CNSLLETTER OF SUSPENSION MAILED—
Oct 19, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 20, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 29, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance